If you had asked HN 3 years ago what would code-generating market would be, they would have used the exact same reasoning and given us the opinion "Why no one will pay for glorified auto-complete"

▲

xboxnolifes 44 minutes ago | parent [-]

Thr pharma parallel to what tech is doing is replacing clinical trials with AI review. Im not so sure its the same thing.

▲

Petersipoi 35 minutes ago | parent [-]

The idea that AI curing cancer, heart disease, aging (you get the idea) won't be a money maker because "clinical trials" is absurd. Of course it will be. Obviously it isn't the same thing as coding agents. But a lot of money makers aren't the same things as coding agents.

	▲	snek_case 21 minutes ago \| parent [-]
		In order to cure cancer with AI, you would need to give it complete control over the experimental pipeline, including probably direct robotic access to a web lab, which comes with its own set of risks. It's just not the same problem space as coding at all.